Authors of a recent review explored the complex relationship between CKD, COVID-19, and anemia and offered practice points based on clinical experience. Patients with chronic kidney disease (CKD) ...

Ziltivekimab, an anti-IL-6 ligand antibody, increases iron and other anemia parameters in patients with chronic kidney disease. Ziltivekimab, a novel anti-IL-6 ligand antibody, improves ...

Nonetheless, the number of CKD-related anemia cases continues to increase, due to population growth, aging, and other factors. Anemia cases attributable to chronic kidney disease (CKD) continue to ...

Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. Let's start with what causes anemia of ...

Background: Chronic kidney disease (CKD) has been linked to higher heart failure (HF) risk. Anemia is a common consequence of CKD, and recent evidence suggests that anemia is a risk factor for HF. The ...

TSUKUBA, JAPAN — Anemia and chronic kidney disease (CKD) are independently associated with an increased risk of new-onset atrial fibrillation (AF), and the combination of the two risk factors is ...

Editor’s note: This is a previously posted video, and the below is an automatically generated transcript to be used for informational purposes. Please notify editor@healio.com if there are concerns ...

SGLT2 inhibitors may be a useful adjunct therapy to reduce anemia risk in patients with type 2 diabetes and early CKD. Anemia risk is lower among patients receiving SGLT2 inhibitors (SGLT2i) compared ...

The latest data suggested that over 40% of adults in the US have chronic kidney disease ; however, CKD shows no symptoms ...